Please Wait.....
Report
Closed System Drug Transfer Device (CSTD) Market? By Type (Membrane to membrane, Needleless) , By Component (Barrier type CSTDs, Air cleaning CSTDs) By End user (Hospitals and Clinics, Oncology Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 216 Pages I Allied Market Research
Closed System Drug Transfer Device (CSTD) Market
The closed system drug transfer device (CSTD) marketwas valued at $0.8 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.
A closed system drug transfer device (CSTD) is a medical equipment which prevents contact between theinner environment of a system and the outer surroundings. CSTD forbids the entry of contaminants from the surroundings into medical equipment or system and prohibits the evasion of hazardous chemicals or vapors from the system to the external environment. These devices are critical for the safety of both patients and the medical professionals working in a hospital setting from probable cytotoxic or teratogenic agents.
With increasing prevalence of cancer and other chronic diseases, the adoption of CSTD is becoming essential in most healthcare settings, hence driving the growth of the market. In addition, implementation of regulatory mandates by several governing bodies such as Occupational Safety and Health Administration and the United States Pharmacopeia is boosting the demand for CSTDs. The integration of CSTDs with automation & robotics is a trend gaining significant prominence in pharmacies and drug preparation facilities to ensure efficient handling and usage of hazardous chemicals.
However, technical hurdles associated with the compatibility of CSTDs with diverse sizes of syringes, drug vials, and infusion systems pose the risk of malfunctions and hamper the development of the closed system drug transfer device (CSTD) market. Moreover, the usage of CSTDs requires high proficiency and specialized training, which is usuallyresource-intensive and laborious. This hampers the market growth. Contrarily, the exponentially rising cases of cancer are anticipated to present lucrative growth opportunities for the market. The number of cancer cases are expected to increase at the rate of 30 million new cases per year by 2040, thereby necessitating the use of CSTDs in hospitals.
Segment Review
The closed system drug transfer device (CSTD) market is segmented into type, component, end user, and region. On the basis of type, the market is bifurcated into membrane to membrane and needleless. Depending on component, it is divided into barrier type CSTDs and air cleaning CSTDs. As per end user, it is categorized into hospitals & clinics, oncology centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the membrane to membrane segment dominates the closed system drug transfer device (CSTD) market.
As per end user, the hospitals & clinics segment holds a high share of the market.
Region wise, North America is the major revenue generator of the closed system drug transfer device (CSTD) market.
Competition Analysis
The key players operating in the global closed system drug transfer device (CSTD) market include B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd., Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd., and Yukon Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Average Selling Price Analysis / Price Point Analysis
- Historic market data
- Reimbursement Scenario
Key Market Segments
By Component
- Barrier type CSTDs
- Air cleaning CSTDs
By End User
- Hospitals and Clinics
- Oncology Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
By Type
- Membrane to membrane
- Needleless
- Key Market Players
- B. Braun Holding GmbH & Co. KG
- Baxter International
- Becton, Dickinson and Company
- Caragen Ltd.
- Corvida Medical
- Equashield
- FIMI Opportunity Funds (Simplivia Healthcare)
- ICU Medical
- JCB Co Ltd.
- Yukon Medical
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: AUTORADIOGRAPHY FILMS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Nuclear Emulsion
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. X-Ray Film
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Others
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: AUTORADIOGRAPHY FILMS MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Blotting
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Sequencing
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: AUTORADIOGRAPHY FILMS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Pharmaceutical And Biotechnology Companies
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Hospitals And Clinics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: AUTORADIOGRAPHY FILMS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Autoradiography Films Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Autoradiography Films Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Autoradiography Films Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Autoradiography Films Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Autoradiography Films Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Autoradiography Films Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Autoradiography Films Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Autoradiography Films Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Autoradiography Films Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Autoradiography Films Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Autoradiography Films Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Autoradiography Films Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. Australia Autoradiography Films Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Autoradiography Films Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Autoradiography Films Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Autoradiography Films Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Autoradiography Films Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Autoradiography Films Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Autoradiography Films Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Thermo Fisher Scientific Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. FUJIFILM Corporation
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Carestream
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. LabScientific
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Danaher Corporation
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Advansta INC
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. PerkinElmer
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Bio-Rad Laboratories, Inc
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Merck KGaA
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Santa Cruz Biotechnology, Inc.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR MEMBRANE TO MEMBRANE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR NEEDLELESS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 5. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR BARRIER TYPE CSTDS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR AIR CLEANING CSTDS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 8. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR ONCOLOGY CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 16. U.S. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 17. U.S. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 18. U.S. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 19. CANADA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 20. CANADA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 21. CANADA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 22. MEXICO CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 23. MEXICO CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 25. EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 26. EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. FRANCE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 30. FRANCE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 31. FRANCE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 32. GERMANY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 33. GERMANY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 34. GERMANY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 35. ITALY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 36. ITALY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 37. ITALY CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 38. SPAIN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 39. SPAIN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 40. SPAIN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. UK CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 42. UK CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 43. UK CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 44. REST OF EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 45. REST OF EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 47. ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 48. ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 51. CHINA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 52. CHINA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 53. CHINA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 54. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 55. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 57. INDIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 58. INDIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 59. INDIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 60. SOUTH KOREA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 61. SOUTH KOREA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 62. SOUTH KOREA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 63. AUSTRALIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 64. AUSTRALIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 65. AUSTRALIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 66. REST OF ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 67. REST OF ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 69. LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 70. LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 73. BRAZIL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 74. BRAZIL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 76. SOUTH AFRICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 77. SOUTH AFRICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 78. SOUTH AFRICA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 79. SAUDI ARABIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 80. SAUDI ARABIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 81. SAUDI ARABIA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 82. REST OF LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 83. REST OF LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 85. B. BRAUN HOLDING GMBH AND CO. KG: KEY EXECUTIVES
TABLE 86. B. BRAUN HOLDING GMBH AND CO. KG: COMPANY SNAPSHOT
TABLE 87. B. BRAUN HOLDING GMBH AND CO. KG: OPERATING SEGMENTS
TABLE 88. B. BRAUN HOLDING GMBH AND CO. KG: PRODUCT PORTFOLIO
TABLE 89. B. BRAUN HOLDING GMBH AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90. BAXTER INTERNATIONAL: KEY EXECUTIVES
TABLE 91. BAXTER INTERNATIONAL: COMPANY SNAPSHOT
TABLE 92. BAXTER INTERNATIONAL: OPERATING SEGMENTS
TABLE 93. BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 94. BAXTER INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 96. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 97. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 98. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 99. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. CARAGEN LTD.: KEY EXECUTIVES
TABLE 101. CARAGEN LTD.: COMPANY SNAPSHOT
TABLE 102. CARAGEN LTD.: OPERATING SEGMENTS
TABLE 103. CARAGEN LTD.: PRODUCT PORTFOLIO
TABLE 104. CARAGEN LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. CORVIDA MEDICAL: KEY EXECUTIVES
TABLE 106. CORVIDA MEDICAL: COMPANY SNAPSHOT
TABLE 107. CORVIDA MEDICAL: OPERATING SEGMENTS
TABLE 108. CORVIDA MEDICAL: PRODUCT PORTFOLIO
TABLE 109. CORVIDA MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110. EQUASHIELD: KEY EXECUTIVES
TABLE 111. EQUASHIELD: COMPANY SNAPSHOT
TABLE 112. EQUASHIELD: OPERATING SEGMENTS
TABLE 113. EQUASHIELD: PRODUCT PORTFOLIO
TABLE 114. EQUASHIELD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : KEY EXECUTIVES
TABLE 116. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : COMPANY SNAPSHOT
TABLE 117. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : OPERATING SEGMENTS
TABLE 118. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : PRODUCT PORTFOLIO
TABLE 119. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120. ICU MEDICAL: KEY EXECUTIVES
TABLE 121. ICU MEDICAL: COMPANY SNAPSHOT
TABLE 122. ICU MEDICAL: OPERATING SEGMENTS
TABLE 123. ICU MEDICAL: PRODUCT PORTFOLIO
TABLE 124. ICU MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125. JCB CO LTD.: KEY EXECUTIVES
TABLE 126. JCB CO LTD.: COMPANY SNAPSHOT
TABLE 127. JCB CO LTD.: OPERATING SEGMENTS
TABLE 128. JCB CO LTD.: PRODUCT PORTFOLIO
TABLE 129. JCB CO LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130. YUKON MEDICAL: KEY EXECUTIVES
TABLE 131. YUKON MEDICAL: COMPANY SNAPSHOT
TABLE 132. YUKON MEDICAL: OPERATING SEGMENTS
TABLE 133. YUKON MEDICAL: PRODUCT PORTFOLIO
TABLE 134. YUKON MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
FIGURE 10. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SEGMENTATION, BY TYPE
FIGURE 11. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR MEMBRANE TO MEMBRANE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR NEEDLELESS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SEGMENTATION, BY COMPONENT
FIGURE 14. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR BARRIER TYPE CSTDS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR AIR CLEANING CSTDS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SEGMENTATION, BY END USER
FIGURE 17. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR ONCOLOGY CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 24. COMPETITIVE DASHBOARD
FIGURE 25. COMPETITIVE HEATMAP: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
FIGURE 26. TOP PLAYER POSITIONING, 2023
FIGURE 27. B. BRAUN HOLDING GMBH AND CO. KG: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. B. BRAUN HOLDING GMBH AND CO. KG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. B. BRAUN HOLDING GMBH AND CO. KG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. BAXTER INTERNATIONAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. BAXTER INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. BAXTER INTERNATIONAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. CARAGEN LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. CARAGEN LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. CARAGEN LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. CORVIDA MEDICAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. CORVIDA MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. CORVIDA MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. EQUASHIELD: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. EQUASHIELD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. EQUASHIELD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : NET SALES, 2021-2023 ($BILLION)
FIGURE 46. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. FIMI OPPORTUNITY FUNDS (SIMPLIVIA HEALTHCARE) : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. ICU MEDICAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. ICU MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. ICU MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. JCB CO LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. JCB CO LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. JCB CO LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. YUKON MEDICAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 55. YUKON MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. YUKON MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security